10-Q: Hercules Capital Reports Strong Q3 Net Income, NAV Growth

Hercules Capital, Inc. reported increased net investment income and net asset value per share for the nine months ended September 30, 2025, despite significant net realized losses.

Summary

• Net increase in net assets resulting from operations rose to $248.9 million for the nine months ended September 30, 2025, up from $201.5 million in the prior year period.
• Total investment income increased to $395.1 million for the nine months ended September 30, 2025, compared to $371.8 million for the same period in 2024.
• Net asset value per share grew to $12.05 as of September 30, 2025, from $11.40 at September 30, 2024.
• The company recorded a net realized loss of $61.0 million for the nine months ended September 30, 2025, a significant decrease from a net realized gain of $1.8 million in the prior year period.
• Net change in unrealized appreciation was $55.2 million for the nine months ended September 30, 2025, a substantial improvement from net unrealized depreciation of $45.0 million in the prior year period.
• Available liquidity stood at $655.0 million as of September 30, 2025, including cash, cash equivalents, foreign cash, and available borrowing capacity under credit facilities.
• Unfunded contractual commitments totaled $437.5 million as of September 30, 2025, with an additional $847.4 million in non-binding term sheets outstanding.
• The weighted average effective yield on debt investments decreased to 13.5% for the three months ended September 30, 2025, from 14.4% in the comparable 2024 period.
• The weighted average core yield on debt investments also decreased to 12.5% for the three months ended September 30, 2025, from 13.3% in the comparable 2024 period.
• Performing investments increased to 98.8% of the total portfolio at amortized cost as of September 30, 2025, up from 98.3% at December 31, 2024, while non-accrual investments decreased to 1.2% from 1.7%.

Sentiment

Score: 6

Explanation: The company shows solid growth in net investment income and NAV, with a positive shift to unrealized appreciation. However, significant realized losses and declining portfolio yields present a mixed financial picture. Strong liquidity and improved non-accrual rates are positive, but macroeconomic risks and a slight deterioration in investment grading warrant a cautious outlook.

Positives

• Net increase in net assets from operations rose to $248.9 million for the nine months ended September 30, 2025, an increase from $201.5 million in the prior year period.
• Net unrealized appreciation of $55.2 million for the nine months ended September 30, 2025, marks a significant improvement from net unrealized depreciation of $45.0 million in the prior year period.
• Total investment income increased to $395.1 million for the nine months ended September 30, 2025, up from $371.8 million in the prior year period.
• Net asset value per share increased to $12.05 as of September 30, 2025, from $11.40 at September 30, 2024.
• The percentage of performing investments improved to 98.8% as of September 30, 2025, from 98.3% at December 31, 2024.
• Non-accrual investments decreased to 1.2% of the total portfolio at amortized cost as of September 30, 2025, down from 1.7% at December 31, 2024.
• The company maintains a strong liquidity position with $655.0 million in available liquidity as of September 30, 2025.
• The number of portfolio companies with debt outstanding increased to 122 as of September 30, 2025, from 118 at December 31, 2024.
• A high percentage of the debt portfolio (97.8%) bears floating rates with interest rate floors, providing insulation against potential declining interest rates.
• The Adviser Subsidiary's assets under management grew by 15.5% to $1,140.4 million as of September 30, 2025.

Negatives

• A net realized loss of $61.0 million was recorded for the nine months ended September 30, 2025, a substantial decline from a net realized gain of $1.8 million in the prior year period, primarily due to write-offs and sales.
• The weighted average effective yield on debt investments decreased to 13.5% for the three months ended September 30, 2025, from 14.4% in the comparable 2024 period.
• The weighted average core yield on debt investments decreased to 12.5% for the three months ended September 30, 2025, from 13.3% in the comparable 2024 period.
• Total return significantly decreased to 1.22% for the nine months ended September 30, 2025, from 26.84% in the prior year period.
• The weighted average investment grading slightly deteriorated to 2.27 as of September 30, 2025, from 2.26 at December 31, 2024.
• Operating activities used $370.2 million in cash for the nine months ended September 30, 2025, a significant increase from $88.8 million used in the prior year period.
• A foreign exchange loss of $2.1 million was recognized for the nine months ended September 30, 2025.

Risks

• Financial results could be negatively affected if significant portfolio investments (e.g., Phathom Pharmaceuticals, Marathon Health, Armis, ChenMed, Shield AI, Tipalti Solutions, SeatGeek) fail to perform as expected.
• Macroeconomic market developments, including inflation, interest rate movements, slowing economic growth, potential global recession, and geopolitical events (Ukraine, Russia, Middle East conflicts), could impact operations, financial position, and cash flows.
• The fair value of investments without readily available market values (Level 3 assets) involves inherent uncertainty and significant judgment, potentially leading to material differences from actual realized values.
• Dependence on the ability to originate new investments, achieve certain margins, and maintain specific debt-to-asset ratios.
• The ability to access debt and equity markets may be constrained by market conditions or regulatory factors.
• Information technology system failures, data security breaches, data privacy compliance issues, network disruptions, and cybersecurity attacks pose operational and financial risks.
• Fluctuations in interest rates could adversely affect the cost of funding and interest income from variable-rate portfolio investments.
• Risk of losses from the warrant portfolio if warrants are terminated or expire unexercised.
• Non-cash PIK income requires cash distributions to stockholders to maintain Regulated Investment Company (RIC) status, potentially impacting liquidity.
• Increased exposure to risks associated with leverage due to the application of a 150% minimum asset coverage ratio.
• Companies contemplating initial public offerings (IPOs) may not complete them in a timely manner or at all.
• Potential involvement in litigation or third-party liability claims could materially affect financial condition or results of operations.

Future Outlook

The company continues to monitor macroeconomic market developments and their related impact on its business, including portfolio companies, employees, and financial markets. It believes it is well-positioned to manage the current environment due to its focus on resilient industries and floating rate debt with interest rate floors. However, the full impact of macroeconomic events on the business, future results of operations, financial position, or cash flows remains unpredictable.

Management Comments

• We believe we and our portfolio are well positioned to manage the current environment.
• Given the unpredictability and fluidity of the macroeconomic market, neither our management nor our Board is able to predict the full impact of the macroeconomic events on our business, future results of operations, financial position, or cash flows.

Industry Context

The company operates in high-growth, innovative venture capital-backed and institutional-backed companies within technology and life sciences sectors. These sectors are characterized by high margins, high growth rates, consolidation, and product and market extension opportunities, with value often vested in intangible assets and intellectual property. The investment portfolio is strategically focused on industries and sectors generally expected to be more resilient to U.S. and global economic cycles.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company may be involved in litigation arising out of its operations in the normal course of business or otherwise.
• Third parties may try to seek to impose liability on the company in connection with the activities of its portfolio companies.
• While the outcome of any current legal proceedings cannot be predicted with certainty, the company does not expect any current matters to materially affect its financial condition or results of operations.

Related Party Transactions

• The Adviser Subsidiary (comprising Hercules Adviser LLC, Hercules Capital Management, LLC, and Hercules Partner Holdings, LLC) is a wholly-owned registered investment adviser business, accounted for as a portfolio investment held at fair value.
• The Adviser Subsidiary provides investment advisory and management services to privately offered Adviser Funds, receiving management fees and potentially incentive fees based on performance.
• The company has a shared services agreement with the Adviser Subsidiary, allocating related expenses of shared services (human capital, infrastructure, technology) based on direct time spent, investment activity, and proportion of assets under management.
• Expenses allocated to the Adviser Subsidiary totaled $4.1 million for the three months ended September 30, 2025, and $10.8 million for the nine months ended September 30, 2025.
• As of September 30, 2025, approximately $0.5 million was receivable from the Adviser Subsidiary and Adviser Funds.
• The company may make investments alongside the Adviser Funds or assign a portion of investments to them in accordance with its allocation policy.
• On July 31, 2025, the company sold $20.0 million of assets to the Adviser Funds at fair value.
• Investment commitments assigned to or directly committed by the Adviser Funds totaled $660.9 million for the nine months ended September 30, 2025.
• Investment fundings assigned to, directly originated, or funded by the Adviser Funds totaled $408.1 million for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders: Experienced an increase in NAV per share and net investment income, but also faced significant net realized losses. Will receive declared quarterly cash distributions.
• Employees and Management: Benefit from equity-based awards granted under the 2018 Equity Incentive Plan and 2018 Non-Employee Director Plan.
• Portfolio Companies: Continue to receive debt financing and unfunded commitments, supporting their growth and operations. Some may also receive advisory services from the Adviser Subsidiary.
• Creditors: The company's debt obligations are secured by assets and are subject to various covenants, with the company reporting compliance with all terms.
• Adviser Funds: Benefit from investment advisory and management services provided by the Adviser Subsidiary, with the company making investments alongside or assigning portions of investments to these funds.

Next Steps

• Continue to make investments in portfolio companies.
• Pay declared cash distributions on November 19, 2025, to stockholders of record as of November 12, 2025.
• Evaluate overall liquidity position and take proactive steps to maintain appropriate liquidity based on current macroeconomic circumstances.
• Monitor and work with management teams and stakeholders of portfolio companies to navigate any significant market, operational, and economic challenges.
• May exercise certain warrants to purchase stock and ultimately monetize investments.
• May seek to retire or repurchase common stock or outstanding debt through various market transactions.

Key Dates

Recommendation

Hercules Capital's latest 10-Q presents a mixed financial performance. While net investment income and NAV per share have grown, indicating underlying business strength and value creation, the significant net realized losses are a concern, reflecting challenges in some portfolio exits or write-offs. The positive shift to unrealized appreciation is encouraging, suggesting a healthier valuation outlook for the remaining portfolio. The company's strong liquidity position and high percentage of performing assets are solid fundamentals. However, the slight decline in portfolio yields and the macroeconomic uncertainties, including interest rate fluctuations, warrant caution. Given the balanced positives and negatives, a 'hold' recommendation is appropriate for seasoned investors. It suggests maintaining current positions to observe how the company navigates the current economic environment and whether it can sustain NAV growth while mitigating realized losses and improving yields.

Keywords

Venture Debt, Specialty Finance, BDC, RIC, Technology, Life Sciences, Senior Secured Loans, Private Equity, Investment Management, SEC Filing, 10-Q, Portfolio Management, Debt Investments, Equity Investments, Warrants, Capital Markets, Interest Rates, Macroeconomics, Asset Coverage Ratio, Unfunded Commitments